Cosmos Health (NASDAQ:COSM – Get Free Report) and ScripsAmerica (OTCMKTS:SCRCQ – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.
Insider & Institutional Ownership
12.6% of Cosmos Health shares are held by institutional investors. 18.7% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
Cosmos Health has a beta of 5.75, suggesting that its share price is 475% more volatile than the S&P 500. Comparatively, ScripsAmerica has a beta of -0.46, suggesting that its share price is 146% less volatile than the S&P 500.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Cosmos Health | -38.19% | -5.83% | -3.29% |
ScripsAmerica | N/A | N/A | N/A |
Valuation & Earnings
This table compares Cosmos Health and ScripsAmerica”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Cosmos Health | $56.45 million | 0.27 | -$18.54 million | N/A | N/A |
ScripsAmerica | N/A | N/A | N/A | N/A | N/A |
ScripsAmerica has lower revenue, but higher earnings than Cosmos Health.
Analyst Recommendations
This is a summary of recent recommendations for Cosmos Health and ScripsAmerica, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Cosmos Health | 0 | 0 | 1 | 0 | 3.00 |
ScripsAmerica | 0 | 0 | 0 | 0 | N/A |
Summary
Cosmos Health beats ScripsAmerica on 5 of the 8 factors compared between the two stocks.
About Cosmos Health
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
About ScripsAmerica
ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Clifton, New Jersey. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2016.
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.